Test a nerve-stimulation approach for heart inflammation
Part of Heart & circulation clinical trials.
This trial studies a nerve-stimulation treatment to affect inflammation and blood vessel function in people with systolic heart failure. If you qualify, it may help improve how your heart and blood vessels work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have systolic heart failure with an ejection fraction (EF) of 50% or less
- You have not had a heart attack within the last 4 weeks, and you are not currently unstable with chest pain
- You do not have any active cancer
- You have not had surgery that cuts the vagus nerve (vagotomy)
- You are not pregnant
- You do not have end-stage liver disease or serious heartbeat/blackout history that would make this unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a gentle electrical stimulation on the ear to see if it can help people with heart failure feel better while they are in the hospital. It might help reduce symptoms and improve heart function.
This trial tests a non-invasive device that sends gentle electrical pulses to a nerve in your ear (vagus nerve) to see if it improves heart function in people with chronic heart failure. If you have heart failure with a reduced pumping ability, you may be able to join.
This trial tests a new treatment that uses a device to calm overactive nerves in the lung's blood vessels. It is for heart failure patients who also have high blood pressure in their lungs, to see if it can help them breathe easier and feel better.
This trial tests a nerve block procedure to improve heart function in people with heart failure and reduced pumping ability. It aims to see if blocking certain nerves can help you feel better and be more active.
This trial tests a procedure called pulmonary artery denervation (using a catheter to treat nerves in the lung's blood vessels) for people with heart failure who still have a preserved ejection fraction (their heart squeezes normally but doesn't fill properly). The procedure aims to reduce pressure in the lungs and improve symptoms like shortness of breath. Participants must be on stable heart failure medications and have elevated BNP levels, among other requirements.
This trial tests a new device that delivers a gentle electrical current to the heart to improve its pumping strength. It is for people with a certain type of heart failure caused by weak heart muscle, not a blocked artery.
Hear when a new Systolic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.